Michael Kaufman

2021

In 2021, Michael Kaufman earned a total compensation of $2.5M as Former Chief Manufacturing Officer at Mersana Therapeutics, a 107% increase compared to previous year.

Compensation breakdown

Option Awards$1,656,619
Salary$286,180
Stock Awards$527,250
Other$40,988
Total$2,511,036

Kaufman received $1.7M in option awards, accounting for 66% of the total pay in 2021.

Kaufman also received $286.2K in salary, $527.3K in stock awards and $41K in other compensation.

Rankings

In 2021, Michael Kaufman's compensation ranked 5,136th out of 12,415 executives tracked by ExecPay. In other words, Kaufman earned more than 58.6% of executives.

ClassificationRankingPercentile
All
5,136
out of 12,415
59th
Division
Manufacturing
2,162
out of 5,505
61st
Major group
Chemicals And Allied Products
931
out of 2,375
61st
Industry group
Drugs
832
out of 2,096
60th
Industry
Pharmaceutical Preparations
596
out of 1,546
61st

Pay ratio

Michael Kaufman's Pay$2,511,036
Median Employee's Pay$302,642
Pay Ratio

8

to 1

In 2021, the annual total compensation of Michael Kaufman was $2,511,036.

The annual total compensation of the median employee at Mersana Therapeutics was $302,642.

The ratio of Michael Kaufman's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 29, 2022.

Kaufman's colleagues

We found six more compensation records of executives who worked with Michael Kaufman at Mersana Therapeutics in 2021.

2021

Anna Protopapas

Mersana Therapeutics

Chief Executive Officer

2021

Timothy Lowinger

Mersana Therapeutics

Senior Vice President, Chief Science and Technology Officer

2021

Brian DeSchuytner

Mersana Therapeutics

Chief Financial Officer

2021

Alejandra Carvajal

Mersana Therapeutics

Chief Legal Officer

2021

Tushar Misra

Mersana Therapeutics

Senior Vice President, Chief Manufacturing Officer

2021

Arvin Yang

Mersana Therapeutics

Chief Medical Officer

News

In-depth

You may also like